Herbal plants and plant preparations as remedial approach for viral diseases

VirusDisease

Volumn 26, Issue 4, 2015, Pages 225-236

  Ganjhu, Rajesh Kumar ^a   Mudgal, Piya Paul ^a   Maity, Hindol ^a   Dowarha, Deepu ^a   Devadiga, Santhosha ^a   Nag, Snehlata ^b   Arunkumar, Govindakarnavar ^a  

^a MANIPAL UNIVERSITY   (India)

^b RANCHI UNIVERSITY   (India)

Author keywords

Antiviral; Ethnopharmacology; Herbal preparations; Patent information; Viral diseases

Indexed keywords

ASTRAGALUS EXTRACT; DIOSCOREA EXTRACT; HERBACEOUS AGENT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; CHINESE MEDICINE; DRUG FORMULATION; DRUG MECHANISM; ETHNOPHARMACOLOGY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICINAL PLANT; NONHUMAN; PATENT; RABIES; REVIEW; VIRUS INFECTION; YAM;

EID: 84948578097     PISSN: 23473584     EISSN: 23473517     Source Type: Journal    
DOI: 10.1007/s13337-015-0276-6     Document Type: Review

References (114)

1. Abdallah RM, Ghazy NM, El-Sebakhy NA, Pirillo A, Verotta L. Astragalosides from Egyptian Astragalus spinosus Vahl. Pharmazie. 1993;48(6):452–4.
2. Alvarez AL, Habtemariam S, Juan-Badaturuge M, Jackson C, Parra F. In vitro anti HSV-1 and HSV-2 activity of Tanacetum vulgare extracts and isolated compounds: an approach to their mechanisms of action. Phytother Res. 2011;25(2):296–301. doi:10.1002/ptr.3382.
3. Babar M, Najam-us-Sahar SZ, Ashraf M, Kazi AG. Antiviral drug therapy- exploiting medicinal plants. J Antivir Antiretrovir. 2013;5:28–36. doi:10.4172/jaa.1000060.
4. Bennerman R, Burton J, Chen WC, eds. Medicinal plants and primary health care: an agenda for action. Traditional medicine and health care coverage; Geneva, Switzerland: World Health Organization; 1983
5. Bertol JW, Rigotto C, de Padua RM, Kreis W, Barardi CR, Braga FC, et al. Antiherpes activity of glucoevatromonoside, a cardenolide isolated from a Brazilian cultivar of Digitalis lanata. Antiviral Res. 2011;92(1):73–80. doi:10.1016/j.antiviral.2011.06.015.
6. Bliah MAM. Anti viral composition. Google Patents; 1987.
7. Chavali SR, Barton LD, Campbell JB. Immunopotentiation by orally-administered Quillaja saponins: effects in mice vaccinated intraperitoneally against rabies. Clin Exp Immunol. 1988;74(3):339–43.
8. Chen GF, Huang WG, Chen FY, Shan JL. Protective effects of trichosanthin in Herpes simplex virus-1 encephalitis in mice. Zhongguo Dang Dai Er Ke Za Zhi. 2006;8(3):239–41.
9. Chen Z-H, Hong-yuan LI, XIE Z-P. Antiviral active compound (RG3-1) from radix gentianae and its anti-RSV activity in vitro. J Harbin Med Univ 2007;4:19.
10. Cheng PW, Chiang LC, Yen MH, Lin CC. Bupleurum kaoi inhibits Coxsackie B virus type 1 infection of CCFS-1 cells by induction of type I interferons expression. Food Chem Toxicol. 2007;45(1):24–31. doi:10.1016/j.fct.2006.06.007.
11. Cheng HY, Huang HH, Yang CM, Lin LT, Lin CC. The in vitro anti-herpes simplex virus type-1 and type-2 activity of Long Dan Xie Gan Tan, a prescription of traditional Chinese medicine. Chemotherapy. 2008;54(2):77–83. doi:10.1159/000119705.
12. Cheng HY, Lin LT, Huang HH, Yang CM, Lin CC. Yin Chen Hao Tang, a Chinese prescription, inhibits both herpes simplex virus type-1 and type-2 infections in vitro. Antiviral Res. 2008;77(1):14–9. doi:10.1016/j.antiviral.2007.08.012.
13. Cheng H-Y, Lin T-C, Yang C-M, Shieh D-E, Lin C-C. In vitro anti-HSV-2 activity and mechanism of action of proanthocyanidin A-1 from Vaccinium vitis-idaea. J Sci Food Agric. 2005;85(1):10–5. doi:10.1002/jsfa.1958.
14. Cheng HY, Yang CM, Lin TC, Lin LT, Chiang LC, Lin CC. Excoecarianin, Isolated from Phyllanthus urinaria Linnea, Inhibits Herpes Simplex Virus Type 2 Infection through Inactivation of Viral Particles. Evid Based Complement Alternat Med. 2011;2011:259103. doi:10.1093/ecam/nep157.
15. Cheng HY, Yang CM, Lin TC, Shieh DE, Lin CC. ent-Epiafzelechin-(4alpha– > 8)-epiafzelechin extracted from Cassia javanica inhibits herpes simplex virus type 2 replication. J Med Microbiol. 2006;55(Pt 2):201–6. doi:10.1099/jmm.0.46110-0.
16. Chiang LC, Ng LT, Cheng PW, Chiang W, Lin CC. Antiviral activities of extracts and selected pure constituents of Ocimum basilicum. Clin Exp Pharmacol Physiol. 2005;32(10):811–6. doi:10.1111/j.1440-1681.2005.04270.x.
17. Chiang LC, Ng LT, Liu LT, Shieh DE, Lin CC. Cytotoxicity and anti-hepatitis B virus activities of saikosaponins from Bupleurum species. Planta Med. 2003;69(8):705–9. doi:10.1055/s-2003-42797.
18. Chin LW, Cheng YW, Lin SS, Lai YY, Lin LY, Chou MY, et al. Anti-herpes simplex virus effects of berberine from Coptidis rhizoma, a major component of a Chinese herbal medicine, Ching-Wei-San. Arch Virol. 2010;155(12):1933–41. doi:10.1007/s00705-010-0779-9.
19. Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW. Treatment of SARS with human interferons. Lancet. 2003;362(9380):293–4.
20. Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet. 2003;361(9374):2045–6.
21. Dao TT, Dang TT, Nguyen PH, Kim E, Thuong PT, Oh WK. Xanthones from Polygala karensium inhibit neuraminidases from influenza A viruses. Bioorg Med Chem Lett. 2012;22(11):3688–92. doi:10.1016/j.bmcl.2012.04.028.
22. Dao TT, Nguyen PH, Lee HS, Kim E, Park J, Lim SI, et al. Chalcones as novel influenza A (H1N1) neuraminidase inhibitors from Glycyrrhiza inflata. Bioorg Med Chem Lett. 2011;21(1):294–8. doi:10.1016/j.bmcl.2010.11.016.
23. Deonarain R, Cerullo D, Fuse K, Liu PP, Fish EN. Protective role for interferon-beta in coxsackievirus B3 infection. Circulation. 2004;110(23):3540–3. doi:10.1161/01.CIR.0000136824.73458.20.
24. Dong CX, Hayashi K, Mizukoshi Y, Lee JB, Hayashi T. Structures and anti-HSV-2 activities of neutral polysaccharides from an edible plant, Basella rubra L. Int J Biol Macromol. 2012;50(1):245–9. doi:10.1016/j.ijbiomac.2011.10.022.
25. Efferth T, Romero MR, Wolf DG, Stamminger T, Marin JJ, Marschall M. The antiviral activities of artemisinin and artesunate. Clin Infect Dis. 2008;47(6):804–11. doi:10.1086/591195.
26. Ellermann-Eriksen S. Autocrine secretion of interferon-alpha/beta and tumour necrosis factor-alpha synergistically activates mouse macrophages after infection with herpes simplex virus type 2. J Gen Virol. 1993;74(Pt 10):2191–9.
27. Fiore C, Eisenhut M, Krausse R, Ragazzi E, Pellati D, Armanini D, et al. Antiviral effects of Glycyrrhiza species. Phytother Res. 2008;22(2):141–8. doi:10.1002/ptr.2295.
28. Gebre-Mariam T, Neubert R, Schmidt PC, Wutzler P, Schmidtke M. Antiviral activities of some Ethiopian medicinal plants used for the treatment of dermatological disorders. J Ethnopharmacol. 2006;104(1–2):182–7. doi:10.1016/j.jep.2005.08.071.
29. Gescher K, Kuhn J, Hafezi W, Louis A, Derksen A, Deters A, et al. Inhibition of viral adsorption and penetration by an aqueous extract from Rhododendron ferrugineum L. as antiviral principle against herpes simplex virus type-1. Fitoterapia. 2011;82(3):408–13. doi:10.1016/j.fitote.2010.11.022.
30. Gescher K, Kuhn J, Lorentzen E, Hafezi W, Derksen A, Deters A, et al. Proanthocyanidin-enriched extract from Myrothamnus flabellifolia Welw. exerts antiviral activity against herpes simplex virus type 1 by inhibition of viral adsorption and penetration. J Ethnopharmacol. 2011;134(2):468–74. doi:10.1016/j.jep.2010.12.038.
31. Getie M, Gebre-Mariam T, Rietz R, Hohne C, Huschka C, Schmidtke M, et al. Evaluation of the anti-microbial and anti-inflammatory activities of the medicinal plants Dodonaea viscosa, Rumex nervosus and Rumex abyssinicus. Fitoterapia. 2003;74(1–2):139–43.
32. Guolun C, Inventor Chinese herbal medicine for treating rabies, 2005.
33. Hassan ST, Masarcikova R, Berchova K. Bioactive natural products with anti-herpes simplex virus properties. J Pharm Pharmacol. 2015;. doi:10.1111/jphp.12436.
34. He W, Han H, Wang W, Gao B. Anti-influenza virus effect of aqueous extracts from dandelion. Virol J. 2011;8:538. doi:10.1186/1743-422X-8-538.
35. Heim A, Canu A, Kirschner P, Simon T, Mall G, Hofschneider PH, et al. Synergistic interaction of interferon-beta and interferon-gamma in coxsackievirus B3-infected carrier cultures of human myocardial fibroblasts. J Infect Dis. 1992;166(5):958–65.
36. Herrmann F, Romero MR, Blazquez AG, Kaufmann D, Ashour ML, Kahl S, et al. Diversity of pharmacological properties in chinese and european medicinal plants: cytotoxicity, antiviral and antitrypanosomal screening of 82 herbal drugs. Diversity. 2011;3(4):547–80.
37. Howard CR, Fletcher NF. Emerging virus diseases: can we ever expect the unexpected? Emerging Microbes Infect. 2012;1:1–11.
38. Hsiang CY, Hsieh CL, Wu SL, Lai IL, Ho TY. Inhibitory effect of anti-pyretic and anti-inflammatory herbs on herpes simplex virus replication. Am J Chin Med. 2001;29(3–4):459–67. doi:10.1142/S0192415X01000472.
39. Huang H, Chan H, Wang YY, Ouyang DY, Zheng YT, Tam SC. Trichosanthin suppresses the elevation of p38 MAPK, and Bcl-2 induced by HSV-1 infection in Vero cells. Life Sci. 2006;79(13):1287–92. doi:10.1016/j.lfs.2006.03.047.
40. Huang W, Zhang X, Wang Y, Ye W, Ooi VE, Chung HY, et al. Antiviral biflavonoids from Radix Wikstroemiae (Liaogewanggen). Chin Med. 2010;5:23. doi:10.1186/1749-8546-5-23.
41. Ida-Hosonuma M, Iwasaki T, Yoshikawa T, Nagata N, Sato Y, Sata T, et al. The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus. J Virol. 2005;79(7):4460–9. doi:10.1128/JVI.79.7.4460-4469.2005.
42. Ikeda K, Tsujimoto K, Uozaki M, Nishide M, Suzuki Y, Koyama AH, et al. Inhibition of multiplication of herpes simplex virus by caffeic acid. Int J Mol Med. 2011;28(4):595–8. doi:10.3892/ijmm.2011.739.
43. Ilic N, Raskin I. Antiviral substances from plant cuticular and epicuticular material. Google Patents; 2003.
44. Jeong HJ, Kim YM, Kim JH, Kim JY, Park JY, Park SJ, et al. Homoisoflavonoids from Caesalpinia sappan displaying viral neuraminidases inhibition. Biol Pharm Bull. 2012;35(5):786–90.
45. Jinsuo S, Inventor Chinese medicine for curing hydrophobia, 2008.
46. Junhai J, inventor Herbal medicine for treating and preventing rabies, 2005.
47. King C. Exhibits tubercin activity; immune enhancers such as glycyrrhizin (GR), glycyrrhetic acid, and Chinese herbal extracts. Google Patents; 2008.
48. Krawitz C, Mraheil MA, Stein M, Imirzalioglu C, Domann E, Pleschka S, et al. Inhibitory activity of a standardized elderberry liquid extract against clinically-relevant human respiratory bacterial pathogens and influenza A and B viruses. BMC Complement Altern Med. 2011;11:16. doi:10.1186/1472-6882-11-16.
49. Kudo E, Taura M, Matsuda K, Shimamoto M, Kariya R, Goto H, et al. Inhibition of HIV-1 replication by a tricyclic coumarin GUT-70 in acutely and chronically infected cells. Bioorg Med Chem Lett. 2013;23(3):606–9. doi:10.1016/j.bmcl.2012.12.034.
50. Kumari B, Kumar S. An insight into the ethnozoology of Panch Pargana area of Jharkand, India. J Threat Taxa. 2009;1(8):441–3.
51. Kutluay SB, Doroghazi J, Roemer ME, Triezenberg SJ. Curcumin inhibits herpes simplex virus immediate-early gene expression by a mechanism independent of p300/CBP histone acetyltransferase activity. Virology. 2008;373(2):239–47. doi:10.1016/j.virol.2007.11.028.
52. Lam PYS. Compositions for the treatment of acquired immunodeficiency disease. Google Patents; 2006.
53. Lee JH, Kwon SM, Seo SH, Park YS, Kim YB, Kim SK, et al. Screening of a natural feed additive having anti-viral activity against influenza A/H5N1. Korean J Food Sci Technol. 2008;28:512–6.
54. Li BQ, Fu T, Dongyan Y, Mikovits JA, Ruscetti FW, Wang JM. Flavonoid baicalin inhibits HIV-1 infection at the level of viral entry. Biochem Biophys Res Commun. 2000;276(2):534–8. doi:10.1006/bbrc.2000.3485.
55. Li Y, Ooi LS, Wang H, But PP, Ooi VE. Antiviral activities of medicinal herbs traditionally used in southern mainland China. Phytother Res. 2004;18(9):718–22. doi:10.1002/ptr.1518.
56. Li T, Peng T. Traditional Chinese herbal medicine as a source of molecules with antiviral activity. Antiviral Res. 2013;97(1):1–9. doi:10.1016/j.antiviral.2012.10.006.
57. Limited P, inventor Antiviral Astragalus Extract, 2006.
58. Lin JC. Mechanism of action of glycyrrhizic acid in inhibition of Epstein-Barr virus replication in vitro. Antiviral Res. 2003;59(1):41–7.
59. Lin LT, Chen TY, Chung CY, Noyce RS, Grindley TB, McCormick C, et al. Hydrolyzable tannins (chebulagic acid and punicalagin) target viral glycoprotein-glycosaminoglycan interactions to inhibit herpes simplex virus 1 entry and cell-to-cell spread. J Virol. 2011;85(9):4386–98. doi:10.1128/JVI.01492-10.
60. Lin LT, Chen TY, Lin SC, Chung CY, Lin TC, Wang GH, et al. Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry. BMC Microbiol. 2013;13:187. doi:10.1186/1471-2180-13-187.
61. Lin LT, Hsu WC, Lin CC. Antiviral natural products and herbal medicines. J Tradit Complement Med. 2014;4(1):24–35. doi:10.4103/2225-4110.124335.
62. Locher CP, Burch MT, Mower HF, Berestecky J, Davis H, Van Poel B, et al. Anti-microbial activity and anti-complement activity of extracts obtained from selected Hawaiian medicinal plants. J Ethnopharmacol. 1995;49(1):23–32.
63. Lubbe A, Seibert I, Klimkait T, van der Kooy F. Ethnopharmacology in overdrive: the remarkable anti-HIV activity of Artemisia annua. J Ethnopharmacol. 2012;141(3):854–9. doi:10.1016/j.jep.2012.03.024.
64. Ma LY, Ma SC, Wei F, Lin RC, But PP, Lee SH, et al. Uncinoside A and B, two new antiviral chromone glycosides from Selaginella uncinata. Chem Pharm Bull (Tokyo). 2003;51(11):1264–7.
65. Mahady GB. Global harmonization of herbal health claims. J Nutr. 2001;131(3):1120S–3S.
66. Matsumori A, Tomioka N, Kawai C. Protective effect of recombinant alpha interferon on coxsackievirus B3 myocarditis in mice. Am Heart J. 1988;115(6):1229–32.
67. Mouhajir F, Hudson JB, Rejdali M, Towers GHN. Multiple antiviral activities of endemic medicinal plants used by berber peoples of morocco. Pharm Biol. 2001;39(5):364–74. doi:10.1076/phbi.39.5.364.5892.
68. Mukherjee H, Ojha D, Bag P, Chandel HS, Bhattacharyya S, Chatterjee TK, et al. Anti-herpes virus activities of Achyranthes aspera: an indian ethnomedicine, and its triterpene acid. Microbiol Res. 2013;168(4):238–44. doi:10.1016/j.micres.2012.11.002.
69. Nagai T, Suzuki Y, Tomimori T, Yamada H. Antiviral activity of plant flavonoid, 5,7,4′-trihydroxy-8-methoxyflavone, from the roots of Scutellaria baicalensis against influenza A (H3N2) and B viruses. Biol Pharm Bull. 1995;18(2):295–9.
70. Nakanishi T, Inada A, Murata H, Iinuma M, Tanaka T, Yamamoto H, et al. Antiviral and Antitumour Activities of Some Western North American Plants with Surface Exudates (1): Inhibitory Effects on HIV-1 Reverse Transcriptase. Jpn J Pharmacogn. 1993;47(3):295–300.
71. Nawaz AHMM, Hossain M, Karim M, Khan M, Jahan R, Rahmatullah M. An ethnobotanical survey of Rajshahi district in Rajshahi division, Bangladesh. American-Eur J Sustain Agric. 2009;3(2):143.
72. Novitsky YA, Madani H, Gharibdoust F, Farhadi M, Farzamfar B, Mohraz M. Use of a combination of ethanolic rosa sp., urtica dioica and tanacetum vulgare extracts, further compromising selenium and urea and having been exposed to a pulsed electromagnetic field, for the preparation of a medicament for immunostimulation and/or treatment of hiv infections. Google Patents; 2009.
73. Numazaki K, Nagata N, Sato T, Chiba S. Effect of glycyrrhizin, cyclosporin A, and tumor necrosis factor alpha on infection of U-937 and MRC-5 cells by human cytomegalovirus. J Leukoc Biol. 1994;55(1):24–8.
74. Obi RK, Iroagba II, Ojiako OA. Virucidal potential of some edible Nigerian vegetables. Afr J Biotechnol. 2006;5(19):1785–8.
75. Paludan SR. Requirements for the induction of interleukin-6 by herpes simplex virus-infected leukocytes. J Virol. 2001;75(17):8008–15.
76. Peng T, Yang Y, Riesemann H, Kandolf R. The inhibitory effect of astragalus membranaceus on coxsackie B-3 virus RNA replication. Chinese medical sciences journal=Chung-kuo i hsueh k’o hsueh tsa chih/Chinese Academy of Medical Sciences. 1995;10(3):146–50.
77. Petrera E, Coto CE. Therapeutic effect of meliacine, an antiviral derived from Melia azedarach L., in mice genital herpetic infection. Phytother Res. 2009;23(12):1771–7. doi:10.1002/ptr.2850.
78. Pleschka S, Stein M, Schoop R, Hudson JB. Anti-viral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian influenza virus (H5N1, H7N7) and swine-origin H1N1 (S-OIV). Virol J. 2009;6:197. doi:10.1186/1743-422X-6-197.
79. Polyak SJ, Morishima C, Lohmann V, Pal S, Lee DY, Liu Y, et al. Identification of hepatoprotective flavonolignans from silymarin. Proc Natl Acad Sci USA. 2010;107(13):5995–9. doi:10.1073/pnas.0914009107.
80. Rates SM. Plants as source of drugs. Toxicon. 2001;39(5):603–13.
81. Rees LP, Minney SF, Plummer NT, Slater JH, Skyrme DA. A quantitative assessment of the antimicrobial activity of garlic (Allium sativum). World J Microbiol Biotechnol. 1993;9(3):303–7. doi:10.1007/BF00383068.
82. Roner MR, Sprayberry J, Spinks M, Dhanji S. Antiviral activity obtained from aqueous extracts of the Chilean soapbark tree (Quillaja saponaria Molina). J Gen Virol. 2007;88(Pt 1):275–85. doi:10.1099/vir.0.82321-0.
83. Saoo K, Miki H, Ohmori M, Winters WD. Antiviral activity of aloe extracts against cytomegalovirus. Phytother Res. 1996;10(4):348–50. doi:10.1002/(SICI)1099-1573(199606)10:4<348:AID-PTR836>3.0.CO;2-2.
84. Sassi AB, Harzallah-Skhiri F, Bourgougnon N, Aouni M. Antiviral activity of some Tunisian medicinal plants against Herpes simplex virus type 1. Nat Prod Res. 2008;22(1):53–65. doi:10.1080/14786410701589790.
85. Shan Y, Zheng Y, Guan F, Zhou J, Zhao H, Xia B, et al. Purification and characterization of a novel anti-HSV-2 protein with antiproliferative and peroxidase activities from Stellaria media. Acta Biochim Biophys Sin (Shanghai). 2013;45(8):649–55. doi:10.1093/abbs/gmt060.
86. Shulong L, Inventor Chinese medicinal herb preparation for treating and preventing rabies, 2008.
87. Singh S, Shenoy S, Nehete PN, Yang P, Nehete B, Fontenot D, et al. Nerium oleander derived cardiac glycoside oleandrin is a novel inhibitor of HIV infectivity. Fitoterapia. 2013;84:32–9. doi:10.1016/j.fitote.2012.10.017.
88. Soltan MM, Zaki AK. Antiviral screening of forty-two Egyptian medicinal plants. J Ethnopharmacol. 2009;126(1):102–7. doi:10.1016/j.jep.2009.08.001.
89. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. How cells respond to interferons. Annu Rev Biochem. 1998;67:227–64. doi:10.1146/annurev.biochem.67.1.227.
90. Toniolo A, Onodera T, Jordan G, Yoon JW, Notkins AL. Virus-induced diabetes mellitus. Glucose abnormalities produced in mice by the six members of the Coxsackie B virus group. Diabetes. 1982; 31 (6 Pt 1):496-9.
91. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol. 2003;3(2):133–46. doi:10.1038/nri1001.
92. Tsai HH, Hwang SM. Compositions of matter useful in the treatment of viral infections derived from plant extracts. Google Patents; 1999.
93. Uncini Manganelli RE. Zaccaro L, Tomei PE. Antiviral activity in vitro of Urtica dioica L., Parietaria diffusa M. et K. and Sambucus nigra L. J Ethnopharmacol. 2005;98(3):323–7. doi:10.1016/j.jep.2005.01.021.
94. Verma H, Patil PR, Kolhapure RM, Gopalkrishna V. Antiviral activity of the Indian medicinal plant extract Swertia chirata against herpes simplex viruses: a study by in vitro and molecular approach. Indian J Med Microbiol. 2008;26(4):322–6.
95. Vijayan P, Raghu C, Ashok G, Dhanaraj SA, Suresh B. Antiviral activity of medicinal plants of Nilgiris. Ind J Med Res. 2004;120(1):24–9.
96. Wang KC, Chang JS, Lin LT, Chiang LC, Lin CC. Antiviral effect of cimicifugin from Cimicifuga foetida against human respiratory syncytial virus. Am J Chin Med. 2012;40(5):1033–45. doi:10.1142/S0192415X12500760.
97. Wang Y, Chen M, Zhang J, Zhang XL, Huang XJ, Wu X, et al. Flavone C-glycosides from the leaves of Lophatherum gracile and their in vitro antiviral activity. Planta Med. 2012;78(1):46–51. doi:10.1055/s-0031-1280128.
98. Wang X, Jia W, Zhao A, Wang X. Anti-influenza agents from plants and traditional Chinese medicine. Phytother Res. 2006;20(5):335–41. doi:10.1002/ptr.1892.
99. Wannang NN, Kwanashie HO, Ede SO. Antiviral Activity of the Fruit Extract of Cucumis metuliferus E. Meye (Curcubitaceae) in Chicks. Afr J Basic Appl Sci. 2010; 2(3–4):89–93.
100. Xiong H-R, Luo J, Hou W, Xiao H, Yang Z-Q. The effect of emodin, an anthraquinone derivative extracted from the roots of Rheum tanguticum, against herpes simplex virus in vitro and in vivo. J Ethnopharmacol. 2011;133(2):718–23. doi:10.1016/j.jep.2010.10.059.
101. Xu HX, Lee SH, Lee SF, White RL, Blay J. Isolation and characterization of an anti-HSV polysaccharide from Prunella vulgaris. Antiviral Res. 1999;44(1):43–54.
102. Yamasaki K, Nakano M, Kawahata T, Mori H, Otake T, Ueba N, et al. Anti-HIV-1 activity of herbs in Labiatae. Biol Pharm Bull. 1998;21(8):829–33.
103. Yang CM, Cheng HY, Lin TC, Chiang LC, Lin CC. Hippomanin A from acetone extract of Phyllanthus urinaria inhibited HSV-2 but not HSV-1 infection in vitro. Phytother Res. 2007;21(12):1182–6. doi:10.1002/ptr.2232.
104. Yang CM, Cheng HY, Lin TC, Chiang LC, Lin CC. The in vitro activity of geraniin and 1,3,4,6-tetra-O-galloyl-beta-d-glucose isolated from Phyllanthus urinaria against herpes simplex virus type 1 and type 2 infection. J Ethnopharmacol. 2007;110(3):555–8. doi:10.1016/j.jep.2006.09.039.
105. Yang T, Jia M, Zhou S, Pan F, Mei Q. Antivirus and immune enhancement activities of sulfated polysaccharide from Angelica sinensis. Int J Biol Macromol. 2012;50(3):768–72. doi:10.1016/j.ijbiomac.2011.11.027.
106. Yang NS, Wang JH, Wei WC. Dioscorea Extracts. Google Patents; 2009.
107. Yarmolinsky L, Zaccai M, Ben-Shabat S, Mills D, Huleihel M. Antiviral activity of ethanol extracts of Ficus binjamina and Lilium candidum in vitro. N Biotechnol. 2009;26(6):307–13. doi:10.1016/j.nbt.2009.08.005.
108. Yarnell E, Abascal K. Herbs for treating herpes zoster infections. Alternat Complement Ther. 2005;11(3):131–4.
109. Yarnell E, Abascal K. Herbal medicine for viral hepatitis. Alternat Complement Ther. 2010;16(3):151–7.
110. Yoosook C, Bunyapraphatsara N, Boonyakiat Y, Kantasuk C. Anti-herpes simplex virus activities of crude water extracts of Thai medicinal plants. Phytomedicine. 2000;6(6):411–9. doi:10.1016/S0944-7113(00)80068-9.
111. Zandi K, Teoh BT, Sam SS, Wong PF, Mustafa MR, Abubakar S. Antiviral activity of four types of bioflavonoid against dengue virus type-2. Virol J. 2011;8:560. doi:10.1186/1743-422X-8-560.
112. Zandi K, Teoh BT, Sam SS, Wong PF, Mustafa MR, Abubakar S. Novel antiviral activity of baicalein against dengue virus. BMC Complement Altern Med. 2012;12:214. doi:10.1186/1472-6882-12-214.
113. Zang N, Xie X, Deng Y, Wu S, Wang L, Peng C, et al. Resveratrol-mediated gamma interferon reduction prevents airway inflammation and airway hyper responsiveness in respiratory syncytial virus-infected immunocompromised mice. J Virol. 2011;85(24):13061–8. doi:10.1128/JVI.05869-11.
114. Zhang GG, Song SJ, Ren J, Xu SX. A new compound from Forsythia suspensa (Thunb.) Vahl with antiviral effect on RSV. J Herb Pharmacother. 2002;2(3):35–40.